Reported as the only form of ribavirin available in a daily, two-pill compliance package designed to enhance therapy adherence, Three Rivers Pharmaceuticals’ Ribasphere® Ribapak for Ribavirin Tablets earned a 2010 Compliance Package of the Year Second Runner Up award from the Healthcare Compliance Packaging Council (HCPC).
Medical literature indicates that adherence to ribavirin therapy is correlated with improved sustained viral response and reduced risk of relapse in the treatment of adults with chronic Hepatitis C.
With Ribasphere® RibaPak, patients take only two ribavirin pills each day—one in the morning and one at night— instead of up to six, reducing the number of ribavirin pills taken over 24 or 48 weeks of treatment. RibaPak packaging is clearly marked for seven days of AM and PM dosing, and the completion of a compliance pack reminds the patient to administer their accompanying weekly interferon therapy. Through this marked packaging and a reduced pill burden, Ribasphere RibaPak is designed and formulated to help the patient adhere to his or her treatment. The package insert includes full prescribing information, as well as warnings, adverse reactions, dosage and administration details. Packaging was done by Sharp Corp.
Warrendale, PA-based Three Rivers Pharmaceuticals is a specialty drug manufacturer dedicated to helping patients by offering them specialized therapies. The company develops, manufactures, and markets branded and generic drug products for patients with serious diseases.
HCPC awarded the winners of its annual Compliance Package of the Year competition at RxAdherence 2011, the organization’s annual conference on patient adherence and compliance prompting packaging issues.
